mutant alpha-1-antitrypsin folding corrector sub-µM in cell, high predicted human %F from 2T component DEL + SBDD Bioorg. Med. Chem. Lett., Mar. 19, 2021 GlaxoSmithKline, Stevenage, UK / UCL